1.Previous
3.Next

approval on 22 May 2017 and European Medicines Agency approval on 23 June 2017.

Development in ankylosing spondylitis has been suspended after the drug failed to show clinical benefit over methotrexate in a phase II trial.

Medical uses

Sarilumab is used for the treatment of moderately to severely active rheumatoid arthritis in people who have not responded to, or did not tolerate, more

1.Previous
3.Next